Ziopharm raises $50M in follow-on

Cancer company Ziopharm Oncology Inc. (NASDAQ:ZIOP) raised $50 million through the sale

Read the full 120 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE